Stock search

Ticker or company name

Compare stocks

Market: US

  • RVTYRevvity
  • CRLCharles River Laboratories
  • TECHBio-Techne

Add stock

Ticker or company

Summary

RVTY
Revvity
$148,85Down −3,59%
Year: Up +65%
56/100Ratio would watch
Open stock page
CRL
Charles River Laboratories
$335,52Down −0,72%
Year: Up +100%
50/100Ratio would watch
Open stock page
TECH
Bio-Techne
$72,79Down −0,01%
Year: Up +20%
69/100Best scoreRatio would watch
Open stock page

Verdict

TECH has the best score (69). RVTY grows revenue the fastest. RVTY is the cheapest by forward P/E. TECH has the lowest debt load. TECH has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckRVTY4 ✓ 2 — 3 ✕CRL4 ✓ 1 — 4 ✕TECH4 ✓ 3 — 1 ✕
P/E vs its history68,1403,062,9
P/E vs industry68,1403,062,9
Forward P/E27,129,534,2
Revenue growth, YoY+4,6%−1,2%+0,9%
EPS growth, YoY+13,1%—+122,4%
Net margin8,6%1,1%n/a—
Net debt / EBITDA2,6−0,5−1,0
Free cash flow$590 m$400 m$308 m
Share count over a year−3,1%−1,7%+1,0%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterRVTYTTMCRLTTMTECHTTMIndustry medianTTM
P/E TTM ↓68,1Worst: 403,0Best: 62,937,9
Forward P/E ↓Best: 27,129,5Worst: 34,229,5
PEG ↓Best: 8,0n/aWorst: 9,83,7
P/S TTM ↓5,9Best: 4,1Worst: 9,46,6
EV/EBITDA ↓Best: 25,8Worst: 82,132,629,9
P/FCF ↓Best: 29,239,1Worst: 43,438,7

Price, %

  • RVTYn/a
  • CRLn/a
  • TECHn/a

Returns

Best WorstNo mark — in between

PeriodRVTYCRLTECH
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

RVTYCRLTECH
Share of “buy”44%Best: 77%Worst: 0%
Beat the forecastBest: 4 of 4Best: 4 of 4Worst: 1 of 4
Average “surprise”Best: +6,7%+4,5%Worst: −0,8%
Insiders over 12 monthssales $5,97 msales $52,1 msales $437 178

Details are on each stock page.